|
Zacks Short Term Rating on DaVita healthCare Partners Inc. (NYSE:DVA) - OTC Outlook |
 |
|
As much as 10 analysts have advised buy on DaVita healthCare Partners Inc. (NYSE:DVA) with an average broker rating of 1.8. Experts at Zacks have given it a short term rating of 2, which means that the investors can Buy for the short term positions. DaVita healthCare Partners Inc. (NYSE:DVA): The mean short term price target for DaVita healthCare Partners Inc. (NYSE:DVA) has been established at $89 per share. The higher price target estimate is at $96 and the lower price target estimate is expected at $83 according to 6 Analyst. The stock price is expected to vary based on the estimate which is suggested by the standard deviation value of $5.66
The company shares have rallied 15.04% in the past 52 Weeks. On April 27, 2015 The shares registered one year high of $85.17 and one year low was seen on July 31, 2014 at $70.41. The 50-day moving average is $82.4 and the 200 day moving average is recorded at $78.86. S&P 500 has rallied 8.87% during the last 52-weeks. DaVita healthCare Partners Inc. (NYSE:DVA) witnessed a decline in the market cap on Monday as its shares dropped 0.07% or 0.06 points. After the session commenced at $83.33, the stock reached the higher end at $83.33 while it hit a low of $82.04. With the volume soaring to 1,264,841 shares, the last trade was called at $82.13. The company has a 52-week high of $85.17. The company has a market cap of $17,653 million and there are 214,941,000 shares in outstanding. The 52-week low of the share price is $70.41.
DaVita HealthCare Partners Inc., formerly DaVita Inc., is a provider of dialysis services in the United States for patients suffering from chronic kidney failure, also known as end stage renal disease (ESRD). As of December 31, 2011, the Company provided dialysis and administrative services through a network of 1,809 outpatient dialysis centers located in the United States throughout 43 states and the District of Columbia, serving a total of approximately 142,000 patients. It also provides acute inpatient dialysis services in approximately 900 hospitals and related laboratory services throughout the United States. In July 2013, DaVita, a division of DaVita HealthCare Partners Inc announced the acquisition of the dialysis operations of Malaysias Caring Dialysis Centre Group (CDC Group) by DVA (Malaysia) Sdn Bhd.
|